One of the most common questions we receive from home care agency owners is simple: “What is my business worth?”
The answer is more nuanced than most owners expect — and often significantly more than they assume. In 2026’s market, quality home care agencies are trading at the highest EBITDA multiples in the sector’s history. But the range is wide, and understanding where your business falls within it is the foundation of any intelligent exit strategy.
This guide explains the valuation methodology buyers use, the factors that move your multiple up or down, and what you can do right now to position your agency for a premium outcome.
The vast majority of home care agency transactions are priced using an EBITDA multiple methodology.
EBITDA = Earnings Before Interest, Taxes, Depreciation, and Amortization
This is your true operating profit — what the business earns after paying all operating expenses, but before financing costs, taxes, and non-cash items. EBITDA is the most commonly used measure because it approximates the cash flow a new owner would receive from the business.
Your valuation = EBITDA × Market Multiple
For example, an agency with $1.2M in EBITDA selling at a 5.5× multiple would have an enterprise value of $6.6M.
| Agency Type | Multiple Range | Typical Buyer |
|---|---|---|
| Non-Medical / Personal Care | 2.0 – 4.5× EBITDA | Regional operators, PE platforms |
| Medical Home Health (Medicare-Certified) | 3.5 – 7.0× EBITDA | PE, national consolidators |
| Hospice | 5.0 – 9.0× EBITDA | PE, regional platforms |
| Multi-Service Platform ($3M+ EBITDA) | 6.0 – 10×+ EBITDA | Top-tier PE, health systems |
Source: Scope Research 2025, BizBuySell 2024, Irving Levin Associates 2024
The multiple you receive within the range depends on approximately a dozen key variables. Here are the ones that matter most:
1. Medicare/Medicaid Revenue Mix Medicare-certified home health agencies command significantly higher multiples than pure private-pay or Medicaid-only agencies. Medicare reimbursement is federal, predictable, and highly attractive to institutional buyers. Medicaid is state-specific and subject to rate compression risk — buyers discount for it.
2. Owner Independence An agency that runs without you — because you have a clinical director, operations manager, and documented processes — is worth dramatically more than one that stops when you go on vacation. Buyers pay premium multiples for businesses that can be transitioned smoothly. An owner-dependent agency frequently sells for 1–2× EBITDA less than an equivalent independent operation.
3. Caregiver Retention The home care industry’s #1 operational challenge is caregiver turnover. Agencies with 70%+ annual caregiver retention rate are perceived as lower-risk and more operationally stable. Buyers systematically discount agencies with chronic turnover problems.
4. Revenue Concentration If any single client, referral source, or payer contract represents more than 20% of your revenue, buyers will apply a discount to reflect the concentration risk. Ideally, no single revenue source exceeds 10–15% of total revenue.
5. Financial Documentation Three years of clean, accountant-prepared financial statements — ideally reviewed or audited — significantly increase buyer confidence and reduce their perceived risk. Agencies with well-organized financials consistently close faster and at better prices.
6. Geographic Market Some markets are more attractive to buyers than others based on regulatory environment, Medicaid reimbursement rates, population demographics, and competitive dynamics. High-demand states (Florida, Texas, California, Ohio) typically command higher multiples than saturated or low-reimbursement markets.
7. EBITDA Growth Trend A business with 15%+ year-over-year EBITDA growth tells a completely different story than one with flat or declining margins. Buyers pay for trajectory, not just size.
One of the most important — and most misunderstood — aspects of home care agency valuation is EBITDA normalization, specifically the calculation of legitimate add-backs.
Add-backs are one-time or above-market expenses that reduce your reported EBITDA but would not be incurred by a new owner. Common examples include:
Properly identifying and documenting add-backs can increase your adjusted EBITDA — and therefore your enterprise value — by 15–30% compared to your raw reported earnings.
Important: Add-backs must be defensible and well-documented. Buyers scrutinize them carefully in due diligence. Poorly documented or aggressive add-backs create negotiation friction and can re-trade your valuation.
While EBITDA multiples are the dominant methodology, some agency types — particularly high-growth, early-stage, or operating-loss companies — may be valued on a revenue multiple instead.
Revenue multiples in home care typically range from 0.3× to 1.2× annual revenue, with higher multiples for Medicare-certified and hospice businesses with strong growth profiles.
In general, if your EBITDA margin is above 10%, an EBITDA-based valuation will produce a higher number. If your margins are below 8%, a revenue-based approach may be more favorable. A skilled advisor will present both methodologies and use whichever produces the strongest case to buyers.
If your current valuation estimate isn’t where you want it to be, there is almost always a path forward. The most impactful improvements are:
Hendon Partners provides confidential valuation estimates based on real transaction data from 150+ home care M&A deals. Schedule a call with our team and receive a detailed valuation analysis within 24 hours.
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.
